FUJIREBIO

FUJIREBIO Overview

Company Headquarters: Tokyo, Japan

Founded: 1950

Workforce: ~ 500

Company Working:

Fujirebio is a global leader in high-quality in-vitro diagnostic (IVD) products. It has 50 years of experience in the conception, development, production, and worldwide commercialization of robust IVD products. It operates through regions such as the US, Latin America, Europe, and Asia. It serves over 80 leading healthcare organizations worldwide. It is one of the worldwide suppliers of high-quality, innovative in-vitro diagnostic (IVD) products. Fujirebio is a part of Miraca Group, a global Japanese healthcare player. It is one of the world leaders in strip-based diagnostic solutions.

Strategy

Fujirebio aims to provide high-quality, innovative services pertaining to healthcare management worldwide. The company strategizes to diversify its product portfolio through strategic acquisitions. Its focus is to improve the quality of life of patients by providing them with better healthcare facilities and better treatment options. The strategy of Fujirebio is to bring solid and successful automated immunoassay testing solutions and state of the art chemiluminescent assay products to the market.

Company Snapshot

500

Employees

1950

Founded

Tokyo, Japan

Headquarters

SWOT Analysis

Strengths

Strong global presence
Well-developed technologies
High investment in research and development of in vitro diagnostic (IVD) products

Weaknesses

Limited presence outside Japan

Opportunities

Enhancing the product portfolio
Expanding in developing regions
Growing demand for healthcare management services

Threats

Stringent government regulations

Key Developments

Date	Approach	Development
April 2019	Product Launch	Fujirebio announced the launch of the Lumipulse G AMH assay. With the help of this assay, anti-Müllerian hormone in human serum can be measured accurately.
April 2017	Product Launch	Fujirebio announced the launch of Lumipulse G HTLV-I/II, a CE-marked CLEIA (chemiluminescent enzyme immunoassay) test kit. These test kits are used for the qualitative detection of antibodies such as HTLV-I and HTLV-II in human serum or plasma for screening of viral infections.

Product Offering

FUJIREBIO
- Chemiluminescence Immunoassay

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.